The 488-amino acid human prostaglandin E 2 receptor EP 4 subtype, which couples to stimulation of adenylyl cyclase, shares the major structural features of G protein-coupled receptors, having seven putative transmembrane domains, an extracellular amino terminus, and a cytoplasmic carboxyl terminus. The latter is composed of 156 amino acids and contains 38 serine and threonine residues, which are potential phosphorylation sites. The carboxyl terminus may be important in receptor function; in some receptors, truncation of the cytoplasmic tail abolishes desensitization. In others, truncation leads to constitutive activity, and in other receptors, truncation has no effect on receptor function. To investigate the role of the long cytoplasmic tail of the EP 4 receptor, we constructed a mutant EP 4 that lacks the last 138 amino acids at the carboxyl terminus, including 36 serine and threonine residues. The truncated EP 4 receptor was stably expressed in Chinese hamster ovary cells at levels comparable to that of the wild-type receptor and exhibited a K d value for [ 3 H]PGE 2 binding similar to that of the wild-type receptor. PGE 2 -mediated adenylyl cyclase activity as a function of PGE 2 concentration was similar in cells expressing the wild-type and truncated EP 4 receptors. Neither the wildtype receptor nor the truncated form showed any constitutive activity. However, the wild-type EP 4 receptor underwent PGE 2 -induced desensitization fully within 15-20 min, whereas the truncated EP 4 receptor, lacking 36 of the 38 carboxyl-terminal serines and threonines, displayed a sustained activation. Despite the continuous presence of PGE 2 , the rate of cAMP synthesis via stimulation of the truncated receptor remained constant over Ն20 min. These findings suggest that the cytoplasmic tail of EP 4 plays an important role in agonist-induced desensitization.
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PGE 2 is involved in many physiological and pathophysiological events (1) , and it exerts its actions through binding to at least four distinct EP receptors that are members of the G protein-linked receptor superfamily (2, 3) . The EP1 receptor couples to phospholipase C, the EP 2 and EP 4 receptors couple to stimulation of adenylyl cyclase, and the EP 3 receptor couples to inhibition of adenylyl cyclase. All of the receptors have been cloned from human cells. In addition, six isoforms of the human EP 3 receptor have been identified that are identical over the first 359 amino acids but differ in the carboxylterminal region, which varies in length from 6 to 65 amino acids after the seventh transmembrane helix (4 -8) . The EP 3 isoforms also differ in their degree of inhibition (4, 5) and susceptibility to desensitization (9) . Truncation of the mouse EP 3 receptor at the splice variant site leads to a fully constitutively active form of the receptor (10) , and some of the isoforms show varying degrees of constitutive activity (10, 11) .
Many cells express several EP receptor subtypes as well as many of the isoforms of EP 3 (4, 5, 7, 8, 12, 13) , which has implications for prostaglandin regulation of cell function. We have shown that coexpression of stimulatory and inhibitory EP receptors leads to a novel form of desensitization of adenylyl cyclase mediated through the EP 3 receptor. Prostaglandins induce time-dependent inhibition with a different concentration dependence from their own activation of adenylyl cyclase (14 -17) . Colocalization of stimulatory and inhibitory receptors may represent a general mechanism of autocrine or paracrine regulation, buffering against rapid variations in agonist concentration when agonists are produced close to their sites of action.
More typically, desensitization of G protein-linked receptors involves phosphorylation by protein kinases at specific serine and threonine residues in the carboxyl-terminal or third intracellular loop of the receptor, leading to attenuation of adenylyl cyclase activity over several minutes (18) . However, because of the possibility of interference from a colocalized EP 3 receptor and its isoforms, this form of desensitization is not readily observed in situ.
For a thorough understanding of the complex system that regulates the PGE 2 -mediated cAMP metabolism, components of the system must be investigated individually and as a whole. We describe experiments on desensitization of the cloned EP 4 receptor expressed in CHO cells, which do not express significant levels of other prostaglandin receptors.
EP 4 is a receptor that was recently identified by Coleman et al. (3) . Its mRNA is abundantly expressed (19 -21) , suggesting that many actions of PGE 2 initially considered to occur through EP 2 may also be exerted through EP 4 . The EP 4 receptor clone was isolated by several groups of researchers, including our group, before the pharmacological identification of EP 4 was made, and the clone was reported as the EP 2 subtype based on the observation that the expressed receptors stimulated adenylyl cyclase (19 -22) . The lack of binding of the EP 2 -selective agonist butaprost was, however, left unexplained in those reports. Identification of EP 4 , and, more recently, isolation of a novel cDNA that when expressed has identical characteristics to the pharmacologically defined EP 2 receptor (23) suggested that the previously reported cDNA clones were the EP 4 subtype. This led Nishigaki et al. to show that the mouse cDNA previously reported as EP 2 (19) was identical to the pharmacologically defined EP 4 subtype (24) . In agreement, we redesignated our cDNA clone from HEL cells as EP 4 . Thus, the cloned receptor studied in the current work was the human EP 4 receptor.
Hydrophobicity analysis of the deduced amino acid sequence of the EP 4 receptor predicts seven hydrophobic segments followed by a long carboxyl-terminal domain of 156 amino acids, including 38 serine and threonine residues, which are potential phosphorylation sites. Among members of the G protein-coupled receptor family, the ␤ 2 -adrenergic receptor has been studied extensively in terms of structureactivity relationship, and its cytoplasmic tail was reported to be important for receptor desensitization (25, 26) . Although the existence of such a relationship was postulated for several members of the family, including the platelet-activating factor receptor (27) and the ␣ 1B -adrenergic receptor (28) , for others, either contradictory findings were reported, such as for the luteinizing hormone receptor (29, 30) , or the same domain was assigned to other functions, such as for the angiotensin II receptor (31) . This inconsistency among different types of receptors suggests that no common criteria can be set for the entire receptor family in terms of structureactivity relationship concerning desensitization and that each receptor, or receptor group, should be evaluated individually regarding that matter. Therefore, it needs to be determined whether the EP 4 receptor undergoes desensitization and whether its long cytoplasmic tail plays a role in the generation of this response.
The cytoplasmic tail of the EP 4 receptor might also be involved in regulation of isomerization between the inactive and active conformations of the molecule as described by Samama et al. for the ␤ 2 -adrenergic receptor (32) . As for the EP 3 receptor isoforms, the structural difference in the cytoplasmic tail not only results in differential G protein coupling but also determines the extent of agonist-independent constitutive activity (10, 11) . Furthermore, a mutant EP 3 receptor truncated at the RNA splicing point retaining the amino acids common to all the isoforms shows full agonist-independent constitutive G i activity (10) . However, the truncated EP 3 receptor shows agonist-dependent G s activity lower than that of EP 3 ␥, the isoform that couples to both G s and G i (11) .
In the current study, we investigated the EP 4 receptor in terms of its signaling properties. In an attempt to underline the significance of the carboxyl-terminal tail, which forms the distal third of the receptor molecule, we engineered a mutant EP 4 that lacks the last 138 amino acids at its carboxyl terminus. The truncation point was homologous to the splicing site of the EP 3 receptor isoforms. However, although truncation of the EP 3 receptor at the splice site results in constitutive activity, truncation of EP 4 receptor led to no change in activity but abolished agonist-induced desensitization. Cloning of the EP 4 receptor cDNA. Total RNA was isolated from mouse kidney by the guanidinium thiocyanate-phenol-chloroform single-step extraction method (33) . First-strand cDNA was synthesized from RNA through reverse transcription with a firststrand synthesis kit. Using the mouse first-strand cDNA as template, PCR was performed with Pfu polymerase with the use of primers based on the mouse EP 4 sequence. The PCR product, corresponding to nucleotides 211-937 of the mouse receptor, was labeled with [␣-32 P]dCTP (3000 Ci/mmol) according to the method of Feinberg and Vogelstein (34, 35) by use of a primer labeling kit from Stratagene. Screening of 6 ϫ 10 5 clones derived from a gt11 HEL cell cDNA library was performed according to the method of Benton and Davis (36) . Hybridization was performed in 10ϫ Denhardt's solution, 5ϫ SSPE (1ϫ ϭ 150 mM NaCl, 10 mM NaH 2 PO 4 , 1.25 mM EDTA, pH 7.4), 100 g/ml salmon sperm DNA, 2% sodium dodecyl sulfate, and 0.1% sodium pyrophosphate at 60°for 20 hr. The final wash was carried out with 0.1ϫ standard saline citrate (1ϫ ϭ 150 mM NaCl, 15 mM sodium citrate, pH 7.0), 0.5% sodium dodecyl sulfate, and 0.1% sodium pyrophosphate at 60°(four washes for 15 min each). Two positive clones were isolated, and the phage DNA was purified with a Magic Lambda Preps kit from Promega (Madison, WI). A single insert of ϳ3.3 kb was obtained from EcoRI digestion of each phage DNA. The inserts were subcloned into pUC18 and sequenced on both strands through use of the dideoxynucleotide chain termination method (37) . The cDNA sequences of the clones phEP 4 -10 and phEP 4 -11 were identical to each other.
Experimental Procedures
Construction of the truncated EP 4 cDNA. To make the cDNA construct, a fragment of phEP 4 extending from the unique SacII site at nucleotide 694 to nucletide 1050, was amplified by PCR. The reverse PCR primer was designed so that the product carried in its 3Ј end three different stop codons located in three different reading frames. An ApaI site was also tagged on the reverse primer. Forward primer was 5Ј-CCACC GCG GCC GCC TCG GTT GCC TCC-3Ј (underlined bases indicate the unique SacII site), and reverse primer was 5Ј-GGA GGG CC (CTA)T(TTA)T(TCA) GCG GCA GAA GAG GCA TTT G-3Ј (underlined bases indicate the tacked-on ApaI site; bases in parentheses indicate stop codons). The 358-bp PCR product was purified after digestion with SacII and ApaI. At the same time, the HindIII insert of phEP 4 was subcloned into pRc/CMV from InVitrogen (San Diego, CA); this was named pRc/CMV-hEP 4 -wt and was used to prepare the cDNA for the truncated receptor. It was digested with SacII and ApaI. The 1939-bp insert was discarded, and the 6773-bp linearized plasmid was purified on a 1% low-meltingtemperature agarose gel. With T4 DNA ligase (Promega), a ligation reaction was performed between the PCR product with SacII/ApaI overhangs and the purified piece of the SacII/ApaI digestion products of pRc/CMV-hEP 4 -wt. The ligation product, named pRc/CMVhEP 4 -t350, was sequenced to ensure sequence accuracy.
Stable expression in CHO-K1 cells. CHO-K1 cells were grown in the nutrient mixture F-12 Ham supplemented with 10% fetal bovine serum at 37°in 5% CO 2 . Transfection of either pRc/CMVhEP 4 -wt or pRc/CMV-hEP 4 -t350 was performed with 7.5 g/ml Lipofectin reagent and 1 g of DNA according to the method of Felgner et al. (38) . Selection medium contained 500 g/ml geneticin sulfate. Single-cell clones were obtained by serial dilution. Positive clones isolated by measuring the PGE 2 -mediated adenylyl cyclase activity were maintained in culture medium containing 10% fetal bovine serum, 350 g/ml geneticin sulfate, and 1 mM acetylsalicylic acid (used to inhibit endogenous PGE 2 formation).
Determination of adenylyl cyclase activity. Transfected cells grown in six-well culture dishes were labeled for 3 hr with 3 Ci of The supernatant and cells were removed from the dishes and boiled for 15 min, and cAMP, which is expressed as percentage of total adenine nucleotides, was determined according to the twocolumn method of Salomon (39) . The kinetic data for each clonal cell line obtained from PGE 2 stimulation were normalized to the corresponding rate of cAMP formation stimulated by 30 M forskolin. Each data point was multiplied by the ratio of postlag phase rate of forskolin-stimulated cAMP synthesis to the initial rate of cAMP synthesis obtained by PGE 2 stimulation.
Binding experiments. Cells stably expressing wild-type or mutant EP 4 were lysed by sonication in 50 mM Tris⅐HCl, pH 7.5, 1 mM EGTA, 10 M leupeptin, and 10 g/ml soybean trypsin inhibitor. The lysate was centrifuged at 36,000 ϫ g for 20 min at 4°. The pellet was washed once and resuspended in buffer A (50 mM Tris⅐HCl, pH 7.5, 10 mM MgCl 2 , 1 mM EGTA, and 10 M leupeptin). Protein concentrations were determined by the Coomassie Plus protein assay reagent (Pierce Chemical, Rockford, IL) (40) . The membrane preparation (0.2-0.8 mg of protein/ml) was incubated with varying concentrations of [ 3 H]PGE 2 for 60 min at room temperature in buffer A. In some experiments, the membrane preparation was incubated with 2.5 nM [
3 H]PGE 2 and varying concentrations of nonlabeled agonist. Binding was determined as described previously (41) except the filters were washed with ice-cold 50 mM Tris⅐HCl, pH 7.5, buffer. To define the nonspecific binding, 1 M nonlabeled PGE 2 was used. The data were analyzed with EBDA software (Biosoft, Cambridge, UK) (42) .
Results
We cloned the cDNA for the PGE 2 receptor EP 4 subtype by probing a gt11 HEL cell cDNA library with a fragment of mouse EP 4 cDNA. The deduced amino acid sequence of our clone (data not shown), although identical to that reported by Bastien et al. (21) , differs from that reported by An et al. (20) in three amino acids: residues 465-467 are Gly-Pro-Ala in our clone but Trp-Ala-Cys in the other. The difference is likely due to sequencing errors. Fig. 1 shows the putative structure of the human EP 4 receptor, including its membrane orientation and the deduced amino acid sequence of the cytoplasmic carboxyl terminus. Thirty eight serine and threonine residues are found within this portion. The truncated (Fig. 1) . Of the 38 serine and threonine residues located in the cytoplasmic tail of the wildtype EP 4 , 36 fall within the deleted fragment. The truncated receptor terminates with the Arg350 and has a 13-amino acid cytoplasmic tail containing two cysteines (Cys346 and Cys349) that may be palmitoylated in analogy to Cys322 and Cys323 of rhodopsin and Cys341 of the ␤ 2 -adrenergic receptor (43) (44) (45) (Fig. 1) .
The cDNA for the wild-type EP 4 receptor or the EP 4 receptor with severely truncated cytoplasmic tail was ligated into the eukaryotic expression vector pRc/CMV, which carries a human cytomegalovirus promoter and a neomycin resistance selection marker. pRc/CMV-hEP 4 -wt or pRc/CMV-hEP 4 -t350 was transfected into CHO-K1 cells. Single-cell cloning was performed by selecting cells resistant to geneticin sulfate through the use of serial dilution, and positive clones were determined with a screen measuring the PGE 2 -mediated adenylyl cyclase activity. Clones that displayed a Ն2-fold increase over the basal level of cAMP in response to 0.1 M PGE 2 were considered to express the transfected receptor. For the wild-type EP 4 , 15 of 40 screened clonal cell lines were positive (37.5%), and for the truncated EP 4 , 24 of 54 screened clonal cell lines were positive (44%).
We selected several clonal cell lines to study the effects of the cytoplasmic tail truncation. The selected clonal cell lines stably expressing the wild-type EP 4 were hEP 4 -wt/CB9 and hEP 4 -wt/AG10, and those stably expressing the truncated EP 4 were hEP 4 -t350/AA6, hEP 4 To determine whether the severe cytoplasmic tail truncation led to any functional changes in the G protein/effector coupling properties of the EP 4 receptor, we measured the PGE 2 -mediated adenylyl cyclase activity. A concentrationdependent increase in the cAMP level was obtained when each selected clonal cell line was challenged with PGE 2 . Fig.  2 shows the PGE 2 -mediated cAMP response obtained in the clonal hEP 4 -wt/CB9 and hEP 4 -t350/AA6 cells. The dose-response curve is typical of those seen in the other selected clonal cells, revealing no significant difference between the dose-response profiles of the wild-type and truncated EP 4 receptors. Notably, saturation of the response could not be obtained regardless of the receptor type, even at PGE 2 concentrations as high as 30 M. The characteristic natures of the dose-response profiles that we obtained, however, are similar to those reported by others for the expressed wildtype human EP 4 receptor (20) .
The basal cAMP level in each clonal cell was also measured to assess any possible alterations in the PGE 2 -independent adenylyl cyclase activity. No significant difference existed between the basal levels of cAMP in cells expressing the wild-type versus the truncated EP 4 receptor, with average basal levels of 0.37 Ϯ 0.07% and 0.38 Ϯ 0.06%, respectively. The basal cAMP level in nontransfected CHO cells (0.30 Ϯ 0.03%) also was similar to that in the clonal cells (Fig. 2) .
To examine whether the wild-type and the truncated EP 4 receptors undergo agonist-mediated desensitization, we challenged the selected clonal cells with PGE 2 (10 M) for varying time periods in the presence of 2 mM IBMX, a phosphodiesterase inhibitor, and measured the amount of cAMP accumulated after each stimulation period. In a separate experiment, we challenged the clonal cells with 30 M forskolin, a direct activator of the adenylyl cyclase, in the same manner. As seen in Fig. 3 , top, which shows the time course of forskolin-stimulated cAMP levels, the specific activities of the cyclase systems of the clonal cell lines were close to each other, with only minor differences. The data in Fig. 3, top, indicate that the rate of forskolin-mediated cAMP formation in each clone was constant throughout the first 30 min, except over the first 4 min, when an apparent lag was ob- served. This lag, which was consistent throughout the clonal cell lines, is likely a reflection of the time required for forskolin to penetrate the cell membrane. The individual rates of cAMP formation were calculated over the time period after the lag phase. The average rate of synthesis was 0.53 Ϯ 0.01%/min among the clonal cells expressing the wild-type receptor and 0.57 Ϯ 0.4%/min for those expressing the truncated receptor. Fig. 3 , bottom, shows the time course of PGE 2 -mediated cAMP formation. The data for each clone were normalized to the corresponding rate of cAMP formation stimulated by 30 M forskolin. The time courses of cAMP formation in Fig. 3 , bottom, indicate grouping of the clonal cell lines into two distinct kinetic patterns. In clonal hEP 4 -wt/CB9 and hEP 4 -wt/AG10, which express the wild-type EP 4 , a linear increase in the cAMP formation was observed over the first 3 min, indicating a constant rate of PGE 2 -mediated activity of adenylyl cyclase. With increasing stimulation time, however, the increase in the cAMP formation curved off and reached a plateau, indicating an incremental decline in the rate of adenylyl cyclase activity (Fig. 3, bottom) . The rate of cAMP synthesis, although initially an average of 0.38 Ϯ 0.02%/min (before normalization) among the clones that express the wild-type EP 4 receptor, approached zero after ϳ15 min of agonist stimulation. The decrease in the rate of cAMP synthesis represents desensitization of adenylyl cyclase because the experiment was performed in the presence of IBMX, which inhibits the breakdown of cAMP. The kinetic pattern in cells expressing the truncated receptor was significantly different. In clonal hEP 4 -t350/AA6, hEP 4 -t350/AD12, and hEP 4 -t350/AE1 cells, the increase in the amount of cAMP remained linear over Ն20 min (i.e., the rate of cAMP synthesis, which averaged 0.36 Ϯ 0.04%/min (before normalization) among the three clones, remained constant (Fig. 3, bottom) . A slight decline in the rate was seen after 20 min of agonist stimulation; however, it was insignificant compared with that observed in cells expressing the wild-type EP 4 receptor. Taken together, the data presented in Fig. 3 indicate a lack of agonist-induced desensitization of the adenylyl cyclase activity in cells expressing the truncated EP 4 receptor.
Discussion
The human PGE 2 receptor EP 4 subtype is a 488-amino acid membrane protein with a significantly long cytoplasmic tail that forms almost one third of the entire molecule. We cloned the wild-type EP 4 receptor from HEL cells and subsequently constructed a cDNA encoding a mutant that lacks part of the carboxyl terminus. We preserved Cys346 and Cys349 in the carboxyl terminus of the truncated EP 4 receptor because a conserved cysteine residue located among the first 15 amino acids of cytoplasmic tails of many G protein-coupled receptors has been implicated in high affinity ligand binding and/or G protein coupling (45, 46) . We truncated the EP 4 receptor at a site homologous to the splice variant site of the EP 3 receptor, which in the case of the EP 3 receptor led to fully constitutive activity (10) .
The binding studies indicate that the deleted portion of the cytoplasmic tail of EP 4 does not seem to be crucial for receptor expression or ligand binding. This suggests that the truncated receptor was processed correctly in terms of post-translational modification, receptor folding, and membrane trafficking. The dose-response studies reveal that the receptor/G protein coupling also is not altered by the truncation of the carboxyl terminus, suggesting that the regions of the molecule involved in G protein coupling are not present within the truncated segment.
In the dose-response experiments, we were unable to saturate the response defined by the increase in the level of cAMP in response to PGE 2 , despite high agonist concentrations. Therefore, an EC 50 value (concentration of agonist yielding half-maximal activity) could not be extrapolated for either the wild-type or the truncated receptor. The rightward shift in the dose-response curve might be due to poor efficiency of the receptor/G protein coupling. The same kind of relationship with a lack of saturation in the cAMP response was reported previously for the cloned human EP 4 receptor expressed transiently (20) . Similar dose-response patterns were also reported for the cloned mouse EP 4 receptor expressed either transiently (19) or stably (24) .
Unlike the truncated EP 3 receptor, truncation of the EP 4 receptor did not result in constitutive activity as judged by the similarity of the basal (agonist-independent) levels of cAMP in the clonal and nontransfected cells. Lack of transformation to a constitutively active state was further sup- ported by the finding that the affinity of the truncated receptor for PGE 2 did not change. Studies involving constitutively active mutant receptor activity have demonstrated that the mutants have significantly higher affinity for agonists (32) . Therefore, it seems that the deleted portion of EP 4 does not play a role in receptor isomerization between inactive and active states.
We studied the effects of truncation on agonist-induced desensitization by using several clonal cell lines expressing either the wild-type or truncated receptor. Our method of measuring desensitization involved measurement of cAMP formation as a function of stimulation time. This allowed us to directly observe the change in the actual rate of PGE 2 -mediated adenylyl cyclase activation. As a control, we also measured the time-course of forskolin-stimulated cyclase activities. We used the rate of cAMP synthesis measured on forskolin stimulation of individual clonal cell lines and normalized the kinetic data obtained from PGE 2 stimulation to take into account the differences in receptor expression levels. The normalization of the data certainly did not alter the kinetic patterns seen when raw data were plotted (data not shown).
This type of desensitization experiment provides reliable data because the experimental conditions allow the system to operate without any interference, such as washing away of the agonist after a certain pretreatment period. In settings in which intact cells are studied, such manipulations can be misleading because it is often hard to completely wash off the agonist or bring down the concentration of the second messenger to normal basal levels before initiation of the stimulation. Lipophilic ligands in particular, such as prostaglandins, are very difficult to remove from the environment, making it almost impossible to achieve accurate concentrations at the receptor site for post-treatment stimulation. We validated the method used in the current study through detailed studies of prostaglandin receptor desensitization in intact cells (16, 17) .
The intrinsic adenylyl cyclase activities of individual clonal cells measured by forskolin stimulation displayed minor variations. This was not unexpected because we have observed such differences among clonal cell lines derived from the same cell type. The difference is due likely to cell-to-cell variations that either exist naturally or were acquired on transfection.
The rate of cAMP formation in response to PGE 2 did not change over Ն20 min in clonal cells expressing the truncated EP 4 receptor. After 20 min, however, a slight decline was observed in the clones hEP 4 -t350/AD12 and hEP 4 -t350/AE1 and, to a lesser extent, in the clone hEP 4 -t350/AA6. This may be due to the onset of other desensitization mechanisms, such as receptor sequestration, which involves removal of the receptor molecules from the cell surface into cellular compartments where ligand interaction is no longer possible (18) . The clonal difference in the extent of this late-onset rate change may be a reflection of the variation in the receptor expression levels. The clone with the highest expression level, hEP 4 t350/AA6, is the least affected, whereas the one with the lowest expression level, hEP 4 -t350/AD12, is the most affected of the three. The change in the rate of synthesis can also be attributed to the removal of inhibition of cAMP phosphodiesterase. IBMX is a competitive inhibitor, and its inhibitory effect can be overcome by increasing concentrations of the substrate, which is cAMP.
By examining agonist-induced desensitization patterns of the wild-type and truncated EP 4 receptors, we showed that the EP 4 receptor-mediated cAMP response is attenuated by continuous agonist exposure and that the cytoplasmic carboxyl terminus has a significant role in this adaptation. In general, desensitization of G protein-coupled receptors involves uncoupling of receptor/G protein complex, sequestration of receptors, and, in the long term, receptor down-regulation (18) . Studies with ␤-adrenergic receptors have indicated the role of phosphorylation by serine/threonine kinases in the uncoupling of receptor from G protein. In the case of ␤ 2 -adrenergic receptor desensitization, ␤-adrenergic receptor kinase phosphorylates multiple sites in the cytoplasmic tail of the agonist-occupied receptor (47) . Our truncated EP 4 receptor is missing 36 serines and threonines in its carboxyl terminus. By analogy to the ␤-adrenergic receptors, these amino acid residues may be phosphorylated in the wild-type on receptor/agonist interaction by ␤-adrenergic receptor kinase or other members of the G protein-coupled receptor kinase family (48) . Proof of this hypothesis requires further investigation involving site-directed mutagenesis methods and direct demonstration of agonist-induced receptor phosphorylation by using specific receptor antibodies. Although such work is currently under way in our laboratory, the results presented in this article clearly demonstrate the requirement of the cytoplasmic tail in desensitization of EP 4 , and help focus further endeavors to this particular region.
In previous work, we have shown that prostaglandin regulation of adenylyl cyclase may involve colocalized stimulatory (EP 2 , EP 4 ) and inhibitory (EP 3 ) receptors, which gives rise to a form of desensitization. The contribution of colocalized receptors to desensitization can be assessed because we can prepare forms of the receptors that do not undergo desensitization by phosphorylation-dependent mechanisms. We have expressed a truncated form of EP 4 that does not desensitize and certain isoforms of EP 3 do not desensitize.
